Juniper Pharm Inc (JNP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2012 | 12-2011 | 12-2010 | 12-2009 | 12-2008 | |
| Sales | 25,828 | 43,062 | 45,676 | 32,196 | 36,229 |
| Cost of Goods | 12,788 | 11,691 | 9,021 | 9,195 | 10,935 |
| Gross Profit | 13,040 | 31,371 | 36,655 | 23,002 | 25,295 |
| Operating Expenses | 11,019 | 9,133 | 35,503 | 36,360 | 33,487 |
| Operating Income | 2,809 | 22,929 | 1,174 | -13,164 | -7,257 |
| Interest Expense | 0 | 0 | 4,838 | 8,851 | 7,882 |
| Other Income | 7,111 | -2,362 | -18,642 | -210 | 199 |
| Pre-tax Income | 9,920 | 20,567 | -22,306 | -22,225 | -14,940 |
| Income Tax | 3 | 39 | -475 | -355 | -864 |
| Net Income Continuous | 9,917 | 20,527 | -21,831 | -21,870 | -14,077 |
| Net Income | $9,917 | $20,527 | $-21,831 | $-21,870 | $-14,077 |
| EPS Basic Total Ops | 0.91 | 1.90 | -2.40 | -3.12 | -2.16 |
| EPS Basic Continuous Ops | 0.91 | 1.90 | -2.38 | -3.10 | -2.15 |
| EPS Diluted Total Ops | 0.26 | 1.73 | -2.40 | -3.12 | -2.16 |
| EPS Diluted Continuous Ops | 0.90 | 1.77 | -2.38 | -3.10 | -2.15 |
| EPS Diluted Before Non-Recurring Items | 0.32 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $3,451 | $23,096 | $5,927 | $-4,535 | $812 |